BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure

J. M. Day, P. A. Foster, H. J. Tutill, S. P. Newman, Y. T. Ho, M. P. Leese, B. V. L. Potter, M. J. Reed, A. Purohit

Research output: Contribution to journalArticlepeer-review

16 Citations (Scopus)


The anti-proliferative and anti-angiogenic properties of the endogenous oestrogen metabolite, 2-methoxyoestradiol (2-MeOE2), are enhanced in a series of sulphamoylated derivatives of 2-MeOE2. To investigate possible mechanisms of resistance to these compounds, a cell line, A2780.140, eightfold less sensitive to the 3,17-O,O-bis-sulphamoylated derivative, STX140, was derived from the A2780 ovarian cancer cell line by dose escalation. Other cell lines tested did not develop STX140 resistance. RT–PCR and immunoblot analysis demonstrated that breast cancer resistance protein (BCRP) expression is dramatically increased in A2780.140 cells. The cells are cross-resistant to the most structurally similar bis-sulphamates, and to BCRP substrates, mitoxantrone and doxorubicin; but they remain sensitive to taxol, an MDR1 substrate, and to all other sulphamates tested. Sensitivity can be restored using a BCRP inhibitor, and this pattern of resistance is also seen in a BCRP-expressing MCF-7-derived cell line, MCF-7.MR. In mice bearing wild-type (wt) and BCRP-expressing tumours on either flank, both STX140 and mitoxantrone inhibited the growth of the MCF-7wt xenografts, but only STX140 inhibited growth of the MCF-7.MR tumours. In conclusion, STX140, a promising orally bioavailable anti-cancer agent in pre-clinical development, is highly efficacious in BCRP-expressing xenografts. This is despite an increase in BCRP expression in A2780 cells in vitro after chronic dosing with STX140.
Original languageEnglish
Pages (from-to)476-486
JournalBritish Journal of Cancer
Issue number3
Publication statusPublished - 3 Feb 2009


  • ovarian cancer
  • breast cancer resistance protein
  • 2-methoxyoestradiol
  • multidrug resistance
  • sulphamate

Fingerprint Dive into the research topics of 'BCRP expression does not result in resistance to STX140 <em>in vivo</em>, despite the increased expression of BCRP in A2780 cells <em>in vitro</em> after long-term STX140 exposure'. Together they form a unique fingerprint.

Cite this